Log in to save to my catalogue

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7987302

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

About this item

Full title

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Publisher

England: Elsevier Ltd

Journal title

The Lancet (British edition), 2021-04, Vol.397 (10282), p.1347-1348

Language

English

Formats

Publication information

Publisher

England: Elsevier Ltd

More information

Scope and Contents

Contents

In April, 2020, in a joint effort, the Coalition for Epidemic Preparedness Innovations (CEPI), the National Institute for Biological Standards and Control (NIBSC), and WHO provided vaccine developers and the entire scientific community with a research reagent for an anti-SARS-CoV-2 antibody. Initiatives have been launched for the harmonisation of i...

Alternative Titles

Full title

WHO International Standard for anti-SARS-CoV-2 immunoglobulin

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7987302

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7987302

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(21)00527-4

How to access this item